You are on page 1of 8

Index

A American College of Clinical Pharmacy Astigmatism, 63


Abbreviations, 128 (ACCP) Athetosis, 83
Abdomen ethical interactions with industry and, Atraumatic. See Normocephalic, atrau-
assessment techniques for 179, 179b matic
auscultation and, 7475, 75f residency and fellowship programs Atrial natriuretic peptide (ANP), 118
inspection and, 74 and, 4 Attending physician, 89
introduction to, 7374, 74b, 74f, 74t American Council on Pharmaceutical Attention, 83
palpation and, 7576, 76f Education (ACPE), 23 Auscultation, 4546
percussion and, 75, 75f American Hospital Formulary Service (AHFS), Auscultatory gap, 52, 53, 53t
terminology for, 76 155 Autoantibody testing, 105
Abdominal reflex, 82 filing systems and, 159 Autonomy, 167
Abdominal respiration, 51, 53 American Medical Association (AMA), Axillae. See Breast and axillae
Abducens nerve (cranial nerve VI), 79, 79t 170172
Abduction, 83 code of ethics and, 170b B
ABO blood typing, 100 American Pharmacists Association (APhA) Babinskis reflex (sign), 82
Abstract reasoning, 78, 83 code of ethics and, 169 Barium study, 99, 99f
Abstract, original research, 161162 conscientious objection and, 174 Barrel chest, 67, 68f, 70
Acalculia, 83 credentialing and, 3 Base excess (BE), 112
Acanthocytes, 103 American Society of Health-System Phar- Basophil, 104
Accessory nerve (cranial nerve XI), 79 macists (ASHP) Basophilic stippling, 104
Acid-fast staining, 108, 108f conscientious objection and, 174 Beaus line, 55
Acoustic nerve (cranial nerve VIII), 79 pharmacists relationship with industry Bells palsy, 63
Acromegaly, 63 and, 179 Beneficence, 167
Acronym residency and fellowship training Bicarbonate, 112
for patient case, 125, 126t and, 4 Bile cast, 115
for physical assessment 43, 44t45t Ammonia, 98 Biliary system, laboratory tests for, 9798
Active listening, 14, 15f Amylase, 96 Bilirubin, 110. See also Indirect bilirubin
Active problem, 135 Anergy panel, 107 dipstick screening and, 113
Activity of daily living (ADL), 78 Angiography, 87, 87f. See also Digital Bilirubin crystals, 115
Adduction, 83 subtraction angiography (DSA) Biomarker, 117119, 117b
Adherence, medication history interview Angiography, coronary, 92 Biopsy, 87
and, 38 Angiokeratoma, 77 Biots respiration, 51f, 53
Adrenal cortex, 95 Anisocytosis, 103 Blackhead. See Comedo
Adrenal medulla, 95 Anosmia, 83 Bleeding time, 100
Adrenal tests, 9596 Anosognosia, 83 Blind spot. See Optic disc
Advance directives, 179180 Antagonistic patient, 20 Blocking, 83
Adverse drug reaction, 37 Anthropometrics, 112 Blood pressure, 5152, 52b, 52f, 53t
questions about, 164 Anti-DNA antibody, 105 Blood smear, 100, 102f
Advisory Commission on Consumer Pro- Antineutrophil cytoplasmic antibody Blood typing. See ABO blood typing
tection and Quality (1997), 170172 (ANCA), 105 Blood urea nitrogen (BUN), 112, 113
Affect, 78, 83 Antinuclear antibody (ANA), 105 Blood, in urine, 113
Agraphia, 83 Aphasia, 83 BMI (body mass index), 53, 55t
Alanine aminotransferase (ALT), 98 Aphonia, 83 Board Certified with Added Qualifica-
Albumin Apnea, 51, 53 tions, 3, 4b
hepatic synthetic function and, 98 Applicability, 161 Board of Pharmacy Specialties (BPS), 3, 3t
nutrition and, 110 Arterial blood gas (ABG), 112 Body mass index (BMI). See BMI
Alcohol, 3435, 35t, 127 respiratory system tests and, 115116 Bone marrow aspiration, 105
Alertness, 78 Arterial pH, 112 Boolean logic, 159
Alkaline phosphatase, 97 Arterial pulse, 50, 50b, 50f Borborygmi, 74, 76
Allergy, medication, 37 Arteriovenous (AV) nicking, 63 Boutonnire deformity, 78
Alpha fetoprotein, 98 Arteriovenous (AV) tapering, 63 Bradycardia, 50, 53, 73
Alternative interventions, 137138 Ascites, 76 Bradypnea, 53
Alternative medicine. See Complementary Ascitic fluid analysis, 98 Brain natriuretic peptide (ANP), 118
and alternative medicine ASHP. See American Society of Health- Breast and axillae, assessment techniques
Alzheimers disease, 119 System Pharmacists (ASHP) for, 73
Ambulatory electrocardiography. See Hol- Aspartate aminotransferase (AST), 98 Breath sounds, 68, 69f
ter monitoring Assessment. See Observation and assess- Bronchial breath sound, 68, 70
American Board of Medical Specialties ment Bronchoscopy, 88, 89f, 116
(ABMS), 6, 7b Asterixis, 83 Bronchovesicular breath sound, 68, 70

Page numbers followed by b, t, and f indicate boxes, tables, and figures respectively.

193
194 Index

Bruit, 73 Chief medical resident, 9 Copper wires, 63


Bulla, 56 Chloride, 113 Corneal arcus, 63
Burr cell, 103 Cholecystography, 99 Costal margin, 76
Cholecystosonography, 99 Costovertebral angle, 76
C Cholesterol, 91 Council on Credentialing in Pharmacy
C peptide, 96 Cholesterol crystals, 115 (CCP), 3
C-reactive protein (CRP) Chorea, 83 Crackles, 68, 70
cardiac biomarkers and, 118 Chronically ill patient, 20 Cranial nerve, 79, 79t
cardiovascular system testing and, 91 Chvosteks sign, 63 Creatinine, 111, 112
immunologic system testing and, 106 Circumstantiality, 83 Creatinine kinase (CK; creatine phos-
infectious disease testing and, 108 Clanging, 83 phokinase), 9091
Calcium, 111. See also Ionized calcium; Clinic, 6 Credentialing
Total calcium Clinical pharmacy multidisciplinary disease-specific, 34
Calcium oxalate crystals, 115, 115f clinical environment for, 511 postlicensure, 3
Calcium pyrophosphate crystals, 106, health care delivery system and, 1112 specialist, 3
107f patient-focused pharmacy practice and, Crepitation, 70, 78
Calculation, 78 15 Crescendo-decrescendo murmur, 72, 73
Cancer biomarker, 119 Clonus, 83 Critically ill patient, 20
Capsule endoscopy, 99 Clothing, interview observation and, 32, Crossmatching, 101
Captopril monitoring parameter, 150, 32f Crust, 57
152f Clubbing, 55, 56f Crystals, 115
Caput medusae, 76 Coagulation tests, 100101 Culturally diverse patient, 20, 20t
Carbon dioxide tension, 112 Code of ethics, 167173 Culture and sensitivity testing, 108, 108f
Carbon monoxide diffusing capacity Code of Federal Regulations (CFR), 174 Current events, 78
(DLCO), 117 Code on Interactions with Healthcare Curschmanns spirals, 116
Carboxyhemoglobin, 103, 116 Professionals, 179 Cystine crystals, 115
Carcinoembryonic antigen (CEA), 98 Cold agglutinin, 105106, 106f, 108 Cytotoxicity toxin assay, 109
Cardiac biomarker, 118119 Cold caloric test, 110
Cardiac catheterization, 92 Colonoscopy, 87, 89f, 99 D
Cardiac enzymes, 90, 94f Color D-Xylose test, 99
Cardiovascular system in ascitic fluid, 99 Data
assessment techniques for in cerebrospinal fluid, 110 group-related, 133
auscultation and, 7173, 71b, 72f, 73t in pleural fluid, 116 history of present illness and, 127
inspection and, 7071, 71f in sputum, 116 medication history interview and, 34b
palpation and, 71, 71b, 72f in urine, 114 pertinent negative, 124, 129
diagnostic tests and procedures for, Coma, 83 pertinent positive, 124, 129
9295 Comedo, 57 Database, computerized bibliographic,
introduction to, 70, 70f Communication skills 159
laboratory tests for, 9092, 93t additional skills of, 2426 Day surgery unit, 5
terminology for, 73 integration and, 1824 Decerebrate rigidity, 83
Carotid artery, auscultation of, 62 obtaining medication history and, Declaration of Helsinki, 174, 175b
Cast, 114115 2930, 30b Decorticate rigidity, 83
Cataract, 60, 60f telecommunication and, 24 Deep hemorrhage, 63
Cell count verbal, 1417 Deep tendon reflex, 8182, 84f
in ascitic fluid, 99 written, 1718 Delirium, 83
in cerebrospinal fluid, 110 Communicative patient, non- or overly, 22 Delta bilirubin, 97, 99
Center for Biologics Evaluation and Re- Community hospital, 6 Dementia, 83
search (CBER), 163 Community of Science (COS), 155 Demographic information, 33
Center for Drug Evaluation and Research Complement, 106 Department of Health and Human Serv-
(CDER), 163 Complement component 3 (C3), 106 ices (DPHHS), 174
Central line placement, 92, 94f Complement component 4 (C4), 106 Design, study, 162
Cerebrospinal fluid (CSF) analysis, 108, Complementary and alternative medi- Dexamethasone suppression test, 95
109 cine, 3637 Diastolic blood pressure (DBP), 52
Certificate program, 35, 4 Complete blood count (CBC), 101 Diastolic murmur, 72, 73
Certification, 3 Computed tomography (CT scan), 87, 87f Diet, 33
Chancre, 77 Condylomata acuminata, 77 Digital subtraction angiography (DSA), 92
Chancroid, 77 Confabulation, 83 Digoxin monitoring parameter, 150, 151f
Charcot-Leyden crystals, 116 Confidentiality, 174 Diopter wheel, 61, 61f
Chest and lung Confusion, 83 Dipstick screening, 113, 114f
assessment techniques for Conjunctival injection, 63 Direct bilirubin, 97
auscultation and, 6870, 69b, 69f Conscientious objection, 173174 Direct Coombs test, 103, 106
inspection and, 6567, 66f, 68f Consensus guideline, 164 Distributive justice, 167
palpation and, 68, 69b Consolidation, 67, 68, 70 Do Not Use list, 123, 125t
percussion and, 67, 68b, 68f Consumer bill of rights, 170172 Documentation
introduction to, 64, 65f, 66f, 67f Continuing education credit (CEU), 3 medication history and, 38, 39f, 40f,
terminology for, 70 Contrast echocardiography, 92 41f, 42b
Cheyne-Stokes respiration, 51, 53 Coombs test, 103, 106. See also Direct Dolls eyes test. See Oculocephalic reflex
Chief complaint (CC), 125 Coombs test Doppler echocardiography, 87, 87f, 92
Index 195

Doppler echography, 87, 87f Esophagogastroduodenoscopy (EGD), 88, G


Dorsiflexion, 78 89f, 99 Gait, 77, 78
Dose, questions about, 163 Ethical issues, 173180 Gallop rhythm, 72, 73
in special situations, 164 Ethics Gamma glutamyl transpeptidase (GGT),
Drug introduction to, 167 98
adverse reaction to, 37 issues in, 168b, 173180 Gastrointestinal system
generic name of, 38 professional codes of, 167173 introduction to, 97, 97t
illicit, 35 Eupnea, 53 laboratory tests for, 9798
Drug compatibility, intravenous admix- Eversion, 78, 83 Generic drug name, 38
ture, 163 Excoriation, 57 Genitourinary system
Drug information center, 162163 Exercise echocardiography, 92 assessment techniques for
Drug information specialist, 163 Exophthalmos, 60, 60f, 63 inspection and, 7677
Drug information, researching and pro- Exploratory biomarker, 118 palpation and, 77
viding of Extension, 78, 79, 83 terminology for, 77
centers for, 162163 External factor Geographic tongue, 63
introduction to, 154, 155b drug intervention and, 136 Gifts, 178
process of, 154162 option elimination and, 137 Glossopharyngeal nerve (cranial nerve
sample questions for, 163164 Extractable nuclear antigen (ENA), 105 IX), 79
Drug intervention, 136137, 136b Extraocular muscle, 5960, 60b, 60f Glucose
Drugs, illicit, 127128 Exudate, 116 cerebrospinal fluid and, 110
Dullness (of percussion note), 67, 70 Eyes, 5962, 62f nutrition and, 111
Dullness, shifting, 76 pancreatic tests and, 96
Durable powers of attorney, 179, 181b F urinalysis and, 113
Dysarthria, 83 Face, 57 Glucose tolerance test (GTT), 96
Dyscalculia, 83 Facial nerve (cranial nerve VII), 79 Glycosylated hemoglobin, 96
Dysgraphia, 83 Family history (FH), 128, 128f Goal, therapeutic, 136137
Dyslexia, 83 Fasciculation, 83 Gram staining, 109, 109f
Dysphasia, 83 Fasting serum glucose, 96 urine and, 113
Dysphonia, 83 Fee-for-service (FFS), 5 Granular cast, 115
Dyspraxia, 83 Fellow, 9 Granulocyte, 104
Dystaxia, 83 Fellowship, 4, 5t Grasp reflex, 82
Dystonia, 83 Fellowship training program, 45 Gravid, 77
Ferritin, 103 Gynecomastia, 73
E Fetor hepaticus, 63
Ear canal, 58 Fibrin degradation product (FDP), 102 H
Ear, external, 58 Fibrinogen, 101 Hair, 57
palpation of, 62 Filing system, 159 palpation of, 62
Ecchymosis, 56 Finger-to-nose test, 79, 81b Hairy tongue, 63
Echocardiography, 92, 103 Fingernail terminology, 55 Hard-to-reach patient, 22
Echography. See Doppler echocardiogra- First-year resident, 9 Head and neck, assessment techniques
phy; Ultrasonography Fissure, 57 for, 5770
Echolalia, 83 Fissured tongue, 63 Head, eyes, ears, nose and throat
Edrophonium test, 110 Flame hemorrhage, 63 (HEENT), 129
Egophony, 70 Flatness (of percussion note), 67, 70 Health care
Ejection clicks, 72, 73 Flexion, 78, 79, 83 clinical environment for, 56, 5b
Elderly patient, 21 Flight of ideas, 83 delivery system of, 1112, 12t
Electrocardiogram (ECG), 9293, 94f, 95f Florence Nightingale Pledge, 170, 170b professional, 68, 6b
with stress, 9394 Fluid character, 116 team, 8, 8f
Electrocardiography, 9294 Fluid wave, 76, 76f Health care professional
Electroencephalography (EEG), 110, 111f Fluoroscopy, 88 communicating with
Electrolytes, 112113 Folate, 103 pharmacist-nurse and, 2324
Electromyography (EMG), 110 Food and Drug Administration (FDA), 156 pharmacist-pharmacist and, 24
Electronic health record (EHR), 18 questions of approved indications by, pharmacist-physician and, 23
Electronic medical record (EMR), 11, 18 163 Health Insurance Portability and Account-
Elliptocyte, 103 Food, interview observation and, 3233 ability Act of 1996 (HIPPA),
Embarrassing situations, 21, 21b, 21f Forced expiratory volume in 1 second 172173
Endocrine system (FEV1), 117 Health maintenance organization (HMO),
introduction to, 95, 96t Foreign Pharmacy Graduate Examination 5, 5t
laboratory tests for, 9597 Committee (FPGEC), 3 Health on the Net Foundation (HON),
Endoscopic retrograde cholangiopancrea- Four-square method, 147, 147f 159
tography (ERCP), 99 Fovea, 62 Hearing, 63, 63f, 64f
Endoscopy, 87, 88f, 89f, 99 Free thyroxine index (FT4I), 97 Hearing impaired patient, 22
Environment, interview observation and, Free will, 167 Heart rate, 50
3233, 32f Freestyle format, 38, 41f Heart sounds, 72
Eosinophil, 104, 116 Fundi, 61 Heel-to-shin test, 81
Epigastric region, 76 Funnel chest, 70 Height, 53
Erythrocyte sedimentation rate (ESR), Furosemide monitoring parameter, 150, Heinz body, 104
103, 106 151f Hematocrit, 103
196 Index

Hematologic system Information sources Koilonychias, 55


diagnostic procedures for, 105 introduction to, 156 Kopliks spots, 63
general laboratory tests for, 100103 primary literature and, 156157 Korotkoff sounds, 52, 53, 53t
introduction to, 100, 100f, 101t secondary and tertiary literature and, Kussmauls respiration, 51, 51f, 53
laboratory tests by specific cell types 157 Kyphoscoliosis, 70
for, 103105 solid oral dosage form identification Kyphosis, 70, 78
Hemianopsia, 83 and, 157
Hemiplegia, 83 Information, critical appraisal of L
Hemodynamic monitory, 92, 94f literature review and, 160161 Lactate dehydrogenase (LDH), 91, 98
Hemoglobin, 103 original research and, 161162 Lasagna, Dr. Louis, 168, 169b
Hemoglobin cast, 115 textbooks and, 160 Lesion, primary, 56
Hemoglobin electrophoresis, 102 Informed consent, 178, 178b Lesion, secondary, 57
Hepatic synthetic function, 98 Inpatient environment, 910, 10f Leucine crystals, 115
Hepatocellular enzyme, 98 Inspection, 43 Leukocyte esterase, 113114
Hernia, 77 Institutional review board (IRB), 174178, Licensure, 23. See also Relicensure
High-density lipoprotein (HDL), 91 178b Lichenification, 57
Hippocratic oath, 168, 168b, 169b Insulin, 96 Life support, 180
confidentiality and, 174 Insulin tolerance test, 9596 Light source, 4950
Hirsutism, 63 Integrated monitoring plan, 150, 152b Lipase, 96
History of present illness (HPI), 125127 Integration List, 78
Hoffmanns reflex, 82 health care professional communica- Literature
Holosystolic murmur, 73 tion and, 2324 primary, 156, 156b
Holter monitoring, 94 patient communication and, 1823 secondary and tertiary, 157, 158b
Hospital, 6 Intention tremor, 83 Literature review, 160161, 161b
Howell-Jolly body, 104 Interleukin-18 (IL-18), 119 Living condition, patient, 128
Human investigation committee (HIC), Internal medicine resident, second-year, 9 Living will, 179, 180b
174. See also Institutional review Internet resource, 159, 160b Long-term goal, 136137
board (IRB) Intervention, patient-specific Loose association, 83
Human research review board (HRRB), alternatives to, 137138 Lordosis, 78
174178. See also Institutional review goals of therapy and, 136137 Low-density lipoprotein (LDL), 91
board (IRB) introduction to, 136 Lung. See Chest and lung
Hydrocele, 77 list of options for, 137 Lupus anticoagulant, 106
Hyperopia, 63 option elimination of, 137 Lymph node, palpation of, 62
Hyperpnea, 53 selection of, 137 Lymphocyte, 104105
Hyperresonance, 67, 70 Interviewing Lymphoscintigraphy, 9495
Hypertension, 52, 53, 73 difficult interview and, 38
Hypochromia, 104 obtaining medication history and, M
Hypogastric region, 76 2931, 31b M-mode echocardiography, 92
Hypoglossal nerve (cranial nerve XII), 79 preparation for, 31 Macrocyte, 104
Hypotension, 53, 73 Intracardiac electrophysiologic study Macula, 62
(EPS), 94 Macule, 56
I Intragastric pH, 99 Magnesium, 111, 113
Ident-A-Drug, 157 Intravenous pyelography (IVP), 115, 116f Magnetic resonance imaging (MRI), 88,
Illicit drug, 35 Invasive test, 86 89f, 90f
Immunization, 37 Inversion, 78, 83 Maintenance of certification (MOC), 6
Immunoelectrophoresis, 106 Iodine, radioactive, 97 Manometry, 99
Immunoglobulin E, 106 Ionized calcium, 113 Manuscript, communication skills and, 26
Immunologic status, 111 Iris, 60 Mastodynia, 73
Immunologic system Iron, 103 Mean cell volume (MCV), 104
diagnostic tests and procedure for, 107 Iron metabolism, 103 Mean corpuscular hemoglobin (MCH), 104
introduction to, 105, 105t Isolation room, interviewing in, 38 Mean corpuscular hemoglobin concentra-
laboratory tests for, 105107 tion (MCHC), 104
Inactive problem, 135 J Media interview, communication skills
Incoherence, 83 Journal Citation Report (JCR), 157 and, 26
India ink preparation, 109 Journal impact factor (JIF), 157 Medical home, 56
Indirect bilirubin, 98 Journals of medicine, 157 Medical intervention, withholding and
Indirect Coombs test, 103, 106 Judgment, 78, 83 withdrawing of, 180
Infectious disease Jugular venous pressure (JVP), 70, 73 Medical jargon, 1920, 19t
introduction to, 107 Junior admitting resident (JAR). See Inter- Medical record, 1011, 11f, 11t
laboratory tests for, 108 nal medicine resident, second-year as written communication tool, 17, 17b
Information accessing Junior medical student, 9 Medical Subject Headings (MeSH), 155
computerized bibliographic database Justice, 167 Medical team, 89, 8b
and, 159 Medicare Modernization Act. See Medicare
individual files and, 159 K Prescription Drug, Improvement and
internet resources and, 159 Keloid, 57 Modernization Act of 2003
introduction to, 157158 Ketones, 113 Medicare Part D, 2
personal digital assistant software and, 160 Kidney biomarker, 119 Medicare Prescription Drug, Improvement
textbooks and, 158159 Kidney injury molecule 1 (Kim1), 119 and Modernization Act of2003, 2
Index 197

Medication Mute patient, 22 Oculovestibular reflex, 82


information dissemination and, 154 Myoclonus, 83 Odor
names of, 33 Myoglobin, 91 of pleural fluid, 116
on demand, 33 Myopia, 63 of sputum, 116
taking history of of urine, 114
checklist for, 42b N Olfactory nerve (cranial nerve I), 79, 79t
data to be obtained and, 3338 Nasal cavity, 58 On demand (PRN) medication, 33
difficult interview and, 38 National Drug Code (NDC), 157 Onycholysis, 55
documentation of, 38 National Patient Safety Goal (NPSG), 29, Opening pressure, 110
introduction to, 2931, 30b, 31b 30b Opening snap, 72, 73
patient observation and, 3133 Neck, 57, 57f. See also Head and neck Ophthalmoplegia, 84
preparation for, 31 Neologism, 83 Ophthalmoscope, 48, 48f, 49t, 6162,
Medication flow sheet, 148, 149f Nerve conduction study, 110 61b, 61f, 62f
Medication history (MedHx), 34b, 128 Neurologic system Optic disc, 62, 62f
Medication reconciliation, 29 cerebellar function assessment and, Optic nerve (cranial nerve II), 79, 79t
Medication regime, 146147 7981, 81b Options, list of, 137
Medication therapy management (MTM), cranial nerve assessment and, 79, 79t Oral case presentation, 123124, 126b
2, 2b diagnostic tests and procedures for, Organ-specific autoantibody, 106
Medication Therapy Services, 2 109110 Orientation, 79
Medline, 155, 159 mental status assessment and, 7879, Orthostatic hypotension, 54, 73
Memory (immediate, short-term, long- 78b Oslers node, 57
term), 78 reflexes and, 8182, 82b, 82f, 83f, 84f Osmolality, 113
Mentally retarded patient, 22 sensory and motor function assessment Otoscope, 48, 49f
Metyrapone test, 96 and, 79, 80f, 81b, 81t Outcome, study, 162
Microaneurysm, 63 terminology for, 8384 Outpatient, environment of, 10, 10f
Microcyte, 104 Neutral range of motion, 78 Ovalocyte, 104
Micromedex, 155 Neutrophil, 104, 116 Oxygen saturation, 112
Midsystolic click, 73 Neutrophil gelatinase-associated lipocalin Oxygen tension, 112
Milium, 57 (NGAL), 119
Minerals, 112113 Nevus, 57 P
Mini-Mental State Examination (MMSE), 78 New England Journal of Medicine, 157 Palpation, 45, 46f
Minimal bactericidal concentration Newsletter, communication skills and, 26 Palpebral fissure, 64
(MBC), 109 Nitrites, 114 Pancreatic tests, 96
Minimal inhibitory concentration (MIC), Nodule, 56 Pansystolic murmur, 73
109 Nondrug intervention, 136137 Papanicolaou (Pap) test, 77
Mixed cellular cast, 115 Noninvasive test, 86 Papule, 56
Mole. See Nevus Nonmaleficence, 167 Paracentesis, 88, 90f
Molecular imaging, 88 Nonprescription medication, 36 Paraparesis, 84
Monitoring drug therapy Normocephalic, atraumatic, 64 Paraplegia, 84
application and integration for, 149, Normochromia, 104 Parathyroid hormone (PTH), 96
150 Normocyte, 104 Parathyroid tests, 96
introduction to, 145, 146b North American Pharmacist Licensure Partial thromboplastin time, activated
process of, 145149, 146b Examination (NAPLEX), 3 (aPTT), 100, 111
Monitoring plan Nose, external, 58 Participant characteristics, 162
assess response to, 149 Nuremberg code, 174, 175b Past medical history (PMH), 127
integration of, 148 Nurse, 7 Patch, 56
monitoring process and, 146 Nurse practitioner (NP), 78 Patch testing, 107, 107f
obtain data for, 148149, 149f Nursing code of ethics, 170, 170b, 171b Patellar reflex, 82b, 82f
parameters of, 146148 Nutrition Pathological reflex, 82, 84t
Monocyte, 105 diagnostic procedures for, 112 Patient
Monofilament test, 79, 81b, 81f introduction to, 110, 111t communication with
Monosodium urate crystals, 106, 107f laboratory tests for, 110112 medical jargon and, 1920
Mood, 83 Nystagmus, 84 patient instruction and, 19
Mouth, 58, 58f, 59t patient titles and, 18
Muddy sclera, 63 O questioning techniques and, 19
Multi-State Pharmacy Jurisprudence Ex- Object recognition, 79 respect and, 1819
amination (MPJE), 3 Objective data, 133134, 134b special situations and, 2023
Multidisciplinary disease-specific creden- Objective data flow sheet, 148, 149f, 151f information, 123, 124b, 125
tialing, 34, 4t Objective, study, 162 observation of, 3133, 32f
Multiple gated acquisition scan (MUGA), Objective-therapeutic monitoring param- problem list, 129
95 eter, 147, 147f, 148 progress, 129130
Murmur, 71b, 72, 73 Objective-toxic monitoring parameter, Patient Care Partnership, 172, 173b
Muscle strength, 79, 81t 147, 147f, 148 Patient case presentation
Musculoskeletal system Observation and assessment, 1415, 15f, 15t chief complaint and, 125
assessment techniques for Occupation, patient, 128 components of, 124125, 126b, 126t
inspection and, 77, 77f Oculocephalic reflex, 82 family history and, 128
palpation and, 7778 Oculomotor nerve (cranial nerve III), 79, general information for, 125
terminology for, 78 79t introduction to, 123124, 124b
198 Index

Patient case presentation (Continued) Physical assessment (Continued) Problem (Continued)


laboratory and test results for, 129 cardiovascular system and, 7073 obtaining patient data for, 132133,
medication history and, 128 chest and lung evaluation and, 134b
other information, 130 6470 prioritization of
past medical history and, 127 equipment for, 4650 active problems and, 135
patient problem list and, 129 genitourinary system and, 7677 inactive problems and, 135
physical examination and, 128129 head and neck inspection and, 5764 ranking of, 135136
present illness history and, 125127 introduction to, 43, 44t Problem-oriented medical record (POMR),
progress and, 129130 musculoskeletal system and, 7778 11
review of systems and, 128 neurologic system and, 7884 Pronation, 84
social history and, 127128 process of, 43 Proprietary drug name, 38
Patient instruction, 19 skin and, 5557 Prostatic hypertrophy, 77
Patient Self-Determination Act (PSDA), 179 vital signs and, 5055 Protein
Patient-centered care. See Patient-focused Physical barrier, verbal communication diagnostic tests and, 110
care and, 15, 16f production of, 98
Patient-focused care. See also Pharmacy Physical examination (PE). See also Physi- urinalysis and, 114
practice, patient-focused cal assessment Protein electrophoresis, 106
clinical pharmacy and, 1, 2f case presentation and, 128129 Prothrombin time (PT), 100
obtaining medication history and, 30, 30b equipment for, 4650 Proxy, 179180
Patients Bill of Rights, 171b process of, 43, 45b PubMed, 155
Patients rights, 170173 Physically challenged patient, 2223 Puddle sign, 75, 76
Peak expiratory flow rate (PEFR), 117 Physician, 6 Pulmonary artery occlusion, 92
Peau dorange, 73 Physician assistant (PA), 8 Pulmonary capillary wedge. See Pulmo-
Pectus excavatum. See Funnel chest Physician code of ethics, 169, 170b nary artery occlusion
Pediatric patient, 22 Physicians Desk Reference (PDR), 157 Pulmonary function testing, 117
Percussion, 4345, 46f Pigeon chest, 70 Pulse oximetry, 117
Percussion hammer. See Reflex hammer Pituitary tests, 97 Pulse, types of, 50, 54
Percutaneous transhepatic cholangiogra- Plantar flexion, 78 Pulsus alternans, 54, 73
phy, 99 Plantar reflex, 82 Pulsus paradoxus, 55, 73
Pericardial friction rub, 72, 73 Plaque, 56 Pupil, 61b
Periorbital edema, 64 Platelets, 103 Pustule, 56
Peripheral nerve stimulation, 110 Platform presentation, 25, 25b, 25f
Peripheral vision, 59, 59f Plethysmography, 88, 90f Q
Peristalsis, 76 Pleural fluid analysis, 116 QT interval prolongation, 118
Perseveration, 84 Pleural friction rub, 70 Quadriplegia, 84
Personal digital assistant (PDA) software, Point of maximal impulse (PMI), 70 Qualifying biomarker, 118
160 Point-of-service plan (POS), 5, 5t Quantitative pilocarpine iontophoresis, 117
Pertinent negative data Poor mans renal biopsy. See Urinary cast Question, drug information
identifying problems and, 132 Positron emission tomography primary, 154155
Pertinent positive data, 132 (PET), 88, 91f sample of, 163164
Petechia, 56 Poster presentation, 2f, 2526 Questioning
pH, 114 Postgraduate year 1. See First-year medication history interview and,
pH stimulation test, 100 resident 3031, 31b
Pharmaceutical care, 1, 2f Postgraduate year 2. See Internal medicine techniques for, 19
Pharmaceutical company, drug informa- resident, second-year
tion and, 156 Postlicensure credentialing, 3, 3f R
Pharmaceutical industry, 178179 Postlicensure residency, 4 Radial deviation, 78
Pharmaceutical Research and Manufactur- Postural tremor, 84 Radiography
ers of America (PhRMA), 179 Potassium, 113 abdominal, 98
Pharmacist Potassium chloride monitoring param- chest, 92, 94f, 116
communication skills for, 1426 eter, 150, 152f standard, 8990, 93f
oath of, 169, 170b Potassium hydroxide preparation (KOH), Radioiodine, thyroid uptake of, 97
Pharmacist communication 109 Radionuclide angiocardiography. See Mul-
with nurse, 2324 Praxis, 79 tiple gated acquisition scan (MUGA)
with other pharmacist, 24 Preferred provider service (PPO), 5, 5t Radionuclide study, 8889, 91f
with physician, 23, 23f Pregnancy, drugs in, 164 Random serum glucose, 96
Pharmacogenetic biomarker, 118, 118t Prescription drug promotion, 178179 Rank-order, of patient problem, 135136
Pharmacy code of ethics, 168169, 169b Prescription medication history, 3536 Rapid alternating movement test, 81
Pharmacy practice, patient-focused Presidents Patients Bill of Rights, 170172, Rapid plasma reagin test (RPR), 109
introduction to, 12 171b Rebound tenderness, 76
requirements for, 23 Prior medical history. See Past medical his- Recent memory, 84
sites and types of, 2, 2b tory (PMH) Red blood cell (RBC)
voluntary credentialing and certificate Privacy, lack of, 1617, 16f laboratory tests of, 103104
programs for, 34 Problem nucleated, 104
Phosphorus, 112, 113 assessment of, 134135 Red blood cell cast, 115, 115f
Physical assessment identification of Red Book, 157
abdomen and, 7376 group-related data for, 133134 Red cell distribution width (RDW), 104
breasts and axillae evaluation and, 73 issue assessment for, 134135 Refereed article, 157
Index 199

Reflex, 8182 Single-photon emission computed tomog- T


Reflex hammer, 49, 49f raphy (SPECT), 89, 92f Tachycardia, 50, 55, 70, 73
Regurgitant murmur, 73 Sinus, 58, 58f Tachypnea, 55
Relicensure, 3. See also Licensure palpation of, 62 Tactile fremitus, 68, 70
Remote memory, 84 Skin Target cell, 104
Renal system assessment techniques for, 55, 57f Teaching hospital, 6
diagnostic procedures for, 115 terminology for, 5557 Teaching, as communication skill, 24
introduction to, 112, 112t Skin-prick testing, 107, 108f Technetium Tc 99m pyrophosphate
laboratory tests for, 112115 Skull, 57 uptake, 95
Renal tubular epithelial cell, 115 palpation of, 62 Telangiectasia, 57
Requirements (pharmacist), 23 Smooth red tongue, 64 spider, 76
Research ethics, 174178 Snellen eye chart, 59 Telecommunication, 24, 24b
Research, original, 161162, 161b Snout reflex, 82 Telephone, verbal communication and,
Residency, 4, 5t SOAP format (subjective, objective, assess- 17
Resident, 9 ment, plan) Temperature, 5253, 54f
Residual volume (RV), 117 drug therapy monitoring and, 145, Tensilon. See Edrophonium test
Resonance, 67, 70 146b Terminally ill patient, 23
Respect, for patient, 18, 18b intervention selection and, 137 Tertiary hospital, 6
Respiration, 5051, 51b, 51f medication history and, 40f Tertiary literature, 157
Respiratory rate, 51, 51f patient problem identification Testing, laboratory and diagnostic
Respiratory system and, 138 background to, 86
diagnostic tests and procedures for, written communication skills and, 18 biomarkers and, 117119
116117 Social drinking, 127 cardiovascular system and, 9095
laboratory tests for, 115116 Social habits, 3335, 35t case presentation and, 129
Resting tremor, 84 Social history (SH), 127128 endocrine system and, 9597
Reticulocyte, 104 Sodium, 113 gastrointestinal system and, 97100
Retraction, 73 Solid oral dosage form, 157 general organ systems and, 8690
Retrograde pyelography, 116f questions of identification for, 163 hematologic system and, 100105
Review of systems (ROS), 128 Specialist credentialing, 3 immunologic system and, 105107
Review, study, 162 Specific gravity, 114 infectious disease and, 107109
Rheumatoid factor (RF), 105 Speech, 79 neurologic system and, 109110
Rheumatoid nodule, 78 Spherocyte, 104 nutrition and, 110112
Rhonchi (rhonchus), 68, 70 Sphygmomanometer, 4748, 47f, 48f, 48t renal system and, 112115
Rinne test, 64 Spider angioma. See Telangiectasia, respiratory system and, 115117
Risk factor, 126127 spider Textbook, 158160
Robert R. Courtney case, 173 Splinter hemorrhage, 55 Thallium stress test, 94
Romberg test, 81 Spoken case presentation, 123, 126b Therapeutic options, list of, 137
Rounds, 10, 10f Sputum analysis, 116 Therapeutics planning. See also SOAP
Rovsings sign, 76 Squamous epithelial cell, 115 format
Standard biomarker, 118 developing monitoring plan in, 138
S Static tremor, 84 drug and nondrug interventions in,
S1, 7172, 73 Station, 78 136138
S2, 7172, 73 Status post (S/P), 127, 135 identifying problem in, 132135
S2, split, 73 Stenosal murmur, 73 introduction to, 132, 133b, 133f
S3, 7172, 73 Stereognosis, 84 prioritizing problems and, 135136
S4, 7172, 73 Stethoscope, 4647, 47f SOAP format and, 138
Scale, 57 Stomatocyte, 104 Therapy assessment, 149, 151b
Scalp, 57 Stool, 98 Thought content, 84
Scaphoid, 76 Stress test, 9394. See also Electrocardio- Thrill, 73
Scar, 57 gram with stress Thrombin time, 101
Schilling test, 100 Striae, 76 Thyroid gland
Schistocyte, 104 Stridor, 68, 70 auscultation of, 62
Scoliosis, 70, 78 Student, medical, 9 palpation of, 62
Scotoma, 84 Stupor, 84 thyroid-stimulating hormone (TSH), 97
Search engine, 159 Subjective data, 133134, 134b Thyrotropin. See Thyroid-stimulating
Search strategy, for drug information, Subjective-therapeutic monitoring param- hormone (TSH)
155156 eter, 146148, 147f Thyrotropin-releasing hormone (TRH), 97
Secondary literature, 157 Subjective-toxic monitoring parameter, Tic, 84
Sepsis, 119 146148, 147f Tidal volume (TV), 117
Serologic tests, 109 Suck reflex, 82 Titles, patient, 18
Serum electrophoresis, 102, 102f Supination, 84 Tobacco smoking, 3435, 35f, 127
Serum protein electrophoresis Suprapubic region, 76 Toenail terminology, 55
(SPEP), 102 Swan-Ganz catheterization, 94f Tongue, 63
Serum/ascites albumin gradient, 99 Sweat test. See Quantitative pilocarpine Tongue depressor, 50
Setting, study, 162 iontophoresis Total bilirubin, 98
Short procedure unit, 5 Synovial fluid analysis, 106 Total calcium, 113
Short-term goal, 136137 Systolic blood pressure (SBP), 52 Total iron-binding capacity (TIBC), 103
Sigmoidoscopy, 100 Systolic murmur, 72, 73 Toxicology, questions about, 164
200 Index

Tracheal breath sound, 70 Urinalysis, 113 Vitamin K-dependent clotting factor, 98


Tracheobronchial breath sound, 70 Urinary cast, 114, 115f Vocabulary, 79
Transaminase, 112 Urinary sodium, 113 Volume, 116
Transesophageal approach (TEE), 92 Urine Voluntary credentialing, 35
Transferrin, 112 macroscopic assessment of, 114
Transferrin saturation, 103 microscopic assessment of, 114115 W
Transthoracic approach (TTE), 92 Urine toxicologic testing, 113 Waist circumference, 53, 55f
Transudate, 116 Urobilinogen, 114 Waist/hip ratio (WHR), 53, 55
Trigeminal nerve (cranial nerve V), 79 Uterus, anteflexed, 77 Ward clerk, 11
Triglyceride (TG), 92 Uterus, anteverted, 77 Webers test, 64, 64f
Triiodothyronine uptake (T3U), 97 Website, drug information and, 159
Trochlear nerve (cranial nerve IV), 79, 79t V Weight, 53
Troponin, 92 Vaccination indication, questions of, 164 Wet mount, 109
Tuning fork, 49, 50f Vagus nerve (cranial nerve X), 79 Wheal, 57
Turbidity, 114 Validity, 161 Wheezes, 68, 70
Two-dimensional echocardiography, 92 Varicocele, 77 Whispered pectoriloquy, 70
Tympanic membrane, 58, 58f Venereal Disease Research Laboratory Test White blood cell (WBC)
Tympany, 70 (VDRL), 107, 109 count and differential of, 109
Tyrosine crystals, 115 Venous blood gas, 116 laboratory tests of, 104105
Ventilation/perfusion (V/Q) scanning, urinalysis and, 115
U 91f, 117 Whitehead. See Milium
U.S. National Library of Medicine (NLM), Verbal communication, 1417, 162 Working lists, 132133
155 Very-low-density lipoprotein (VLDL), 92 Written case presentation, 123
Ulcer, 57 Vesicle, 57 Written communication, 162
Ulnar deviation, 77, 78 Vesicular breath sounds, 70 skills for, 1718
Ultrasonography, 90, 93f Viscosity, 116
Umbilical region, 76 Vital signs X
United States Medical Licensing Examina- assessment techniques for, 5053 Xanthelasma, 64
tion (USMLE), 6, 7t case presentation and, 129
University of Kentucky Drug Information techniques for, 5053
Center, 162163 terminology of, 5354
Uric acid, 106 Vitamin B12, 100, 104